Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes - Gaertner, S; Cordeanu, EM; Nouri, S (Int J Cardiol, 2017)
et al.